$TRIB News

Trinity Biotech Enters Collaboration With Intradermal Drug Delivery Platform Maker Latch Medical

Trinity Biotech Announces ADS Ratio Change From One ADS Representing 20 Ordinary Shares To One ADS Representing 600 Ordinary Shares

Trinity Biotech Announces Clinical Study Results Showing Next-Gen CGM+ Wearable Biosensor Platform Delivers Purpose-Built Capability To Identify Nocturnal Compression-Related False Low Glucose Events

Trinity Biotech’s Unit Trinovium Secures Silver Membership In Open Compute Project To Directly Engage With Global Ecosystem Shaping Next-Gen Data Center Infrastructure

Trinity Biotech Terminates Standby Equity Purchase Agreement With YA II

Trinity Biotech Launches Trinovium, Subsidiary Focused On Advanced Liquid Cooling Solutions And Fluid Intelligence Systems For Next-Gen AI Data Centers

Trinity Biotech Q1 EPS $(0.23) Up From $(0.48) YoY, Sales $10.846M Up From $7.570M YoY

Trinity Biotech Secures Additional Purchase Orders For 2M+ TrinScreen HIV Tests, For Q3 2026 Delivery

Trinity Biotech Launches $4,352,314 At-The-Market ADS Offering Through Lucid Capital

Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations

Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test

Trinity Biotech Announces Successful Clinical Test Results For New Prostate Cancer Test AI-Incorporated Algorithm

Trinity Biotech Expects Q4 Revenue Range ~$11.5M - $12.5M

Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

Trinity Biotech Receives Nasdaq Noncompliance Letter

Trinity Biotech Receives Nasdaq Noncompliance Letter

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement

Trinity Biotech Receives Nasdaq Noncompliance Notice

Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation